JP2017513516A5 - - Google Patents

Download PDF

Info

Publication number
JP2017513516A5
JP2017513516A5 JP2017501094A JP2017501094A JP2017513516A5 JP 2017513516 A5 JP2017513516 A5 JP 2017513516A5 JP 2017501094 A JP2017501094 A JP 2017501094A JP 2017501094 A JP2017501094 A JP 2017501094A JP 2017513516 A5 JP2017513516 A5 JP 2017513516A5
Authority
JP
Japan
Prior art keywords
microorganism
cancer
recombinant chimeric
group
chimeric adi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017501094A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017513516A (ja
JP6612316B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/021189 external-priority patent/WO2015143006A1/en
Publication of JP2017513516A publication Critical patent/JP2017513516A/ja
Publication of JP2017513516A5 publication Critical patent/JP2017513516A5/ja
Application granted granted Critical
Publication of JP6612316B2 publication Critical patent/JP6612316B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017501094A 2014-03-18 2015-03-18 操作されたキメラpeg化adi及び使用方法 Active JP6612316B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461954929P 2014-03-18 2014-03-18
US61/954,929 2014-03-18
PCT/US2015/021189 WO2015143006A1 (en) 2014-03-18 2015-03-18 Engineered chimeric pegylated adi and methods of use

Publications (3)

Publication Number Publication Date
JP2017513516A JP2017513516A (ja) 2017-06-01
JP2017513516A5 true JP2017513516A5 (cg-RX-API-DMAC7.html) 2018-04-26
JP6612316B2 JP6612316B2 (ja) 2019-11-27

Family

ID=54145261

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017501094A Active JP6612316B2 (ja) 2014-03-18 2015-03-18 操作されたキメラpeg化adi及び使用方法

Country Status (7)

Country Link
US (1) US10463721B2 (cg-RX-API-DMAC7.html)
EP (1) EP3119421B1 (cg-RX-API-DMAC7.html)
JP (1) JP6612316B2 (cg-RX-API-DMAC7.html)
KR (2) KR102353046B1 (cg-RX-API-DMAC7.html)
CN (1) CN106794229B (cg-RX-API-DMAC7.html)
SG (1) SG11201607736UA (cg-RX-API-DMAC7.html)
WO (1) WO2015143006A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014151982A2 (en) 2013-03-15 2014-09-25 Polaris Group Arginine deiminase with reduced cross-reactivity toward adi – peg 20 antibodies for cancer treatment
WO2015143006A1 (en) 2014-03-18 2015-09-24 Tdw Group Engineered chimeric pegylated adi and methods of use
CA2961602A1 (en) 2014-09-16 2016-03-24 Polaris Group Arginine deiminase with reduced cross-reactivity toward adi - peg 20 antibodies for cancer treatment
US12281339B2 (en) 2016-07-05 2025-04-22 Polaris Group Combination cancer immunotherapies with arginine depletion agents
EP3534963B1 (en) * 2016-11-02 2024-04-17 Polaris Group Formulations of pegylated arginine deiminase
CN106591270B (zh) 2017-01-23 2018-09-21 江南大学 一株定点突变改造的基因工程精氨酸脱亚胺酶
US12344645B2 (en) 2017-03-29 2025-07-01 Polaris Group Protein conjugates
WO2020009740A2 (en) 2018-04-25 2020-01-09 Washington University Compositions and methods of use thereof for treatment of metabolic diseases and related disorders
WO2022063178A1 (en) * 2020-09-23 2022-03-31 The Hong Kong Polytechnic University Fluorescent biosensor for rapid determination of l-arginine
KR102640230B1 (ko) * 2021-09-24 2024-02-22 가천대학교 산학협력단 C-peptide를 처리한 자궁내막 기질세포의 이동성 변화 기작을 이용한 자궁내막 관련질환의 진단 방법 및 자궁내막 관련질환 치료제의 스크리닝 방법
EP4580657A4 (en) * 2022-09-02 2026-02-18 Polaris Group Modified Arginine Deiminases

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2900279B2 (ja) 1989-08-02 1999-06-02 株式会社ジャパンエナジー 新規なアルギニンデイミナーゼ、その製造法及び該酵素を有効成分とする制癌剤
US5372942A (en) 1992-02-10 1994-12-13 Coriell Institute For Medical Research Protease K resistant arginine deiminase, its method of preparation and its use as an anti-neoplastic agent
US5804183A (en) 1997-01-31 1998-09-08 Enzon, Inc. Arginine deminase derived from mycoplasma arthritidis and polymer conjugates containing the same
US6635462B1 (en) * 1997-05-12 2003-10-21 Phoenix Pharmacologies, Inc. Mutated form of arginine deiminase
US6183738B1 (en) 1997-05-12 2001-02-06 Phoenix Pharamacologics, Inc. Modified arginine deiminase
US6180387B1 (en) * 1997-08-11 2001-01-30 Smithkline Beecham Corporation Arginine deiminase
IT1298918B1 (it) 1998-02-20 2000-02-07 Mendes Srl Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
WO2002009741A1 (en) 2000-07-27 2002-02-07 Angiolab, Inc. The pharmaceutical composition comprising arginine deiminase for inhibiting angiogenesis
AU2001289132A1 (en) * 2000-11-28 2002-06-11 Phoenix Pharmacologics, Inc. Modified arginine deiminase
ES2477118T3 (es) 2002-11-18 2014-07-15 Polaris Group Método para inhibir la replicaci�n viral in vivo
AU2004235382A1 (en) 2003-04-29 2004-11-11 Wyeth Methods for diagnosing AML and MDS differential gene expression
US20070212311A1 (en) 2003-10-07 2007-09-13 University Of Florida Research Foundation, Inc. Recombinant Alkalinizing Bacteria
CN101002945B (zh) 2006-01-20 2012-09-05 清华大学 一种用于肿瘤治疗的新型复合物
WO2009006590A2 (en) 2007-07-04 2009-01-08 Dr. Reddy's Laboratories Ltd. Docetaxel process and polymorphs
US20090238813A1 (en) 2007-12-28 2009-09-24 Board Of Regents, The University Of Texas System Compositions And Methods For Engineered Human Arginine Deiminases
US20120015049A1 (en) 2009-01-14 2012-01-19 Lin Zhang Microrna biomarker in cancer
WO2011053871A2 (en) 2009-10-30 2011-05-05 Life Technologies Corporation Multi-primer assay for mycoplasma detection
WO2011151704A2 (en) 2010-06-02 2011-12-08 Fresenius Kabi Oncology Ltd. Stable pharmaceutical compositions of rapamycin esters
WO2012075173A2 (en) 2010-12-01 2012-06-07 Board Of Regents The University Of Texas System Compositions and method for deimmunization of proteins
US8663967B2 (en) 2011-08-22 2014-03-04 Jiangsu T-Mab Biopharma Co., Ltd. Arginine deiminase mutant and preparation and application thereof
JP2014521602A (ja) 2012-04-04 2014-08-28 ポラリス グループ アルギニンデイミナーゼを用いる処置方法
WO2014151982A2 (en) * 2013-03-15 2014-09-25 Polaris Group Arginine deiminase with reduced cross-reactivity toward adi – peg 20 antibodies for cancer treatment
WO2015143006A1 (en) 2014-03-18 2015-09-24 Tdw Group Engineered chimeric pegylated adi and methods of use
CA2961602A1 (en) 2014-09-16 2016-03-24 Polaris Group Arginine deiminase with reduced cross-reactivity toward adi - peg 20 antibodies for cancer treatment

Similar Documents

Publication Publication Date Title
RU2015141932A (ru) Аргининдеиминаза с пониженной перекрестной реактивностью к антителам adi-peg 20 для лечения рака
JP2016519069A5 (cg-RX-API-DMAC7.html)
Yin et al. Reconfiguring the architectures of cationic helical polypeptides to control non-viral gene delivery
JP6243452B2 (ja) アルブミン結合アルギニンデイミナーゼ融合たんぱく質を含有する医薬組成物
JP2013509861A5 (cg-RX-API-DMAC7.html)
JP2017006120A5 (cg-RX-API-DMAC7.html)
JP2017529366A5 (cg-RX-API-DMAC7.html)
JP2021505661A5 (cg-RX-API-DMAC7.html)
RU2018131636A (ru) Новые конъюгаты аманитина
Ranji et al. Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance
JP2017523781A5 (cg-RX-API-DMAC7.html)
JP2016521688A5 (cg-RX-API-DMAC7.html)
JP2013515745A5 (cg-RX-API-DMAC7.html)
RU2021130306A (ru) Композиции il-12, нацеленные на edb
JP2010524968A5 (cg-RX-API-DMAC7.html)
Pourhadi et al. Expression, purification, and cytotoxic evaluation of IL24-BR2 fusion protein
US20170096452A1 (en) Novel Tumor-Targeting Compounds
BR112012013139A2 (pt) oligopeptídeos imp-3 e vacinas incluindo os mesmos
Ghavimi et al. Exploring the potential of anticancer peptides as therapeutic agents for cancer treatment
CN119462857B (zh) 一种多肽及其在制备预防和/或治疗癌症药物中的应用
MX2012011668A (es) Peptidos cdca5 y vacunas que incluyen los mismos.
WO2015053413A1 (ja) ドライバーオンコジーンの遺伝子変異を標的にアルキル化する新規アルキル化剤
JP2023544201A5 (cg-RX-API-DMAC7.html)
JP2022516054A5 (cg-RX-API-DMAC7.html)
JP2018526987A5 (cg-RX-API-DMAC7.html)